Wacker Chemie stock comes into this earnings day on the back foot, with the share price down roughly 5% over the past three months and trading near €88.5 at the latest close. The headline shock is not the top line. It is the profit swing. Net income in Q2 2026 sits at €340.8m, helped by a Siltronic related gain, and basic earnings per share jump to €6.84 from €0.21 in Q1. The market now has to decide whether this sharp profit recovery reflects a healthier chemicals business or a one quarter reset.
Love the sharp profit rebound at Wacker Chemie but unsure how much is due to one off gains rather than ongoing earnings power? Compare it with companies in our 526 high quality undiscovered gems.
Tired of scrolling through dense earnings tables and rows of figures? Get a clear, visual read on Wacker Chemie with a full breakdown of its valuation picture in the company report for Wacker Chemie.
The bullish story on Wacker Chemie is that higher value silicones and semiconductor polysilicon, helped by cost and efficiency programs, can lift utilization and margins even without a strong macro rebound. Q2 results give some concrete milestones on that front. Group sales reached €1.52b with EBITDA before pension effects at €175m, and management attributes the improvement mainly to the PACE savings program, pricing, mix and higher volumes rather than any broad demand surge.
Silicones and Polymers are doing the heavy lifting that this thesis needs. Silicones delivered €757m sales and €123m EBITDA, with management now expecting mid single digit sales growth and a higher EBITDA margin for the year. Polymers posted €406m sales and €69m EBITDA, again with guidance for growth and a margin above last year. Semiconductor grade polysilicon volumes are rising and inventory is lower, which partly supports the idea of better utilization, although segment EBITDA of €11m shows pricing pressure still bites.
Reveal where the surface looks calm, yet the multi year models quietly diverge, and identify the point at which the consensus view on Wacker Chemie really starts to break. Access the full revenue and earnings analyst estimates for Wacker Chemie.The cautious view on Wacker Chemie is that heavy energy use, overcapacity and weak polysilicon pricing keep margins fragile and cash flow at risk. Q2 does not fully dismiss that concern. Polysilicon EBITDA of €11m on €226m sales points to thin profitability despite roughly 10% higher semiconductor volumes in the first half. Management still flags solar weakness, higher energy costs and uncertainty around U.S. trade measures, which fits the bear argument that external conditions remain tough.
On costs, the PACE program delivered about €45m savings in Q2 and €85m in the first half, yet a large part of the future benefit depends on German headcount cuts that mainly show from 2027. That means structural energy and regulatory pressure is not yet clearly neutralised. Cash generation is helped by lower capex and inventory, but net debt of €722m and a Siltronic gain driven EPS spike leave the underlying earnings and free cash flow story still unproven.
With Wacker Chemie still unprofitable over several years and net debt at €722m, your real risk is cash discipline rather than headline EPS. Check the full balance sheet, liquidity and cash flow stress test in our financial health analysis of Wacker Chemie stock.If the sharp profit swing and Siltronic driven gain at Wacker Chemie caught your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch how earnings quality develops. Once you own Wacker Chemie or other stocks, keep a clear view of what matters with the Portfolio Command Center that filters out noise and highlights key changes in fundamentals. For a broader lens on what other investors are seeing, tap into the Community and compare your thesis with different viewpoints. This way you can spot hidden catalysts and risks earlier and stay ahead of the market.
Fresh ideas move fast. Some stocks are building breakout momentum while others are still under the radar for now. Scan these curated shortlists before the crowd and get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com